Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor ε1 subunit

Journal of Neuroscience

Volumn 21, Issue 2, 2001, Pages 750-757

  Miyamoto, Yoshiaki ^a   Yamada, Kiyofumi ^a   Noda, Yukihiro ^a   Mori, Hisashi ^b   Mishina, Masayoshi ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Dopaminergic neuronal system; GluR 1 subunit; Hyperlocomotion; NMDA receptor; Schizophrenia; Serotonergic neuronal system

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BICUCULLINE; CALCIUM 45; CARBON 14; DIZOCILPINE; DOPAMINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RISPERIDONE; SEROTONIN; TRITIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LEARNING; MENTAL DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; TASK PERFORMANCE;

EID: 0035862965     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-02-00750.2001     Document Type: Article

References (53)

1. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine
2. Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification
3. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease
4. Disruption of selective attention by apomorphine, but not amphetamine, in the Mongolian gerbil
5. Effects of atypical antipsychotic agents on social behavior in rodents
6. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
7. Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene
8. Clozapine: An atypical antipsychotic agent
9. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death
10. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
11. New antipsychotics: Classification, efficacy, and adverse effects
12. Serotonergic functions in arousal and motor activity
13. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
14. 3H]dopa in various regions of the brain
15. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
16. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability
17. Cloned glutamate receptors
18. Differential effects of pimozile and SCH23390 on acquisition of learning in mice
19. Dopaminergic agonists impair latent learning in mice: Possible modulation by noradrenergic function
20. Reduced spontaneous activity of mice defective in the ε4 subunit of the NMDA receptor channel
21. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus
22. Recent advances in the phencyclidine model of schizophrenia
23. Effects of risperidone on phencyclidine-induced behaviors: Comparison with haloperidol and ritanserin
24. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor ε1 subunit
25. Local GABAergic regulation of the NMDA-evoked release of dopamine is more important in striosomes than in matrix of the rat striatum
26. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor ε2 subunit mutant mice
27. Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity
28. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knock-out mice
29. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats
30. Study of a new schizophrenomimetic drug, Sernyl
31. The spectrum of behaviors influenced by serotonin
32. Intracelular injections of EGTA block induction of hippocampal long-term potentiation
33. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission
34. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
35. The physiology of excitatory amino acids in the vertebrate central nervous system
36. The mechanism of action of novel antipsychotic drugs
37. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats
38. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
39. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex
40. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
41. Measurement of dissociation of amnesic and behavioral effects of drugs in mice
42. Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task
43. Molecular diversity and functions of glutamate receptors
44. Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly
45. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: A new model of schizophrenia
46. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit
47. The catecholamine hypothesis of affective disorders: A review of supporting evidence
48. Antipsychotic drug doses and neuroleptic/dopamine receptors
49. Drugs, neurotransmitters, and schizophrenia
50. Schizophrenia and glutamatergic transmission
51. Neuropharmacological characterization of voltage-sensitive calcium channels: Possible existence of neomycin-sensitive, ω-conotoxin GVIA- and dihydropyridine-resistant calcium channels in the rat brain
52. 3H]MK-801 in brain synaptic membranes treated with Triton X-100
53. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques